Shares of Hims & Hers Health (HIMS 23.96%) and LifeMD (LFMD 37.21%) are surging on Tuesday. The companie' stocks had jumped 24% and 34%, respectively, as of 3:15 p.m. ET as the S&P 500 and the Nasdaq Composite showed modest gains.Shares soared after pharma giant Novo Nordisk announced it will distribute its blockbuster GLP-1 weight loss drug Wegovy through telehealth platforms like Hims & Hers and LifeMD.Wegovy is popularNovo Nordisk announced it will sell Wegovy directly through telehealth providers includ ...